HREC fees & payments

Please contact the Research Office by phone only on tel: 02 8382 4960 for a Fee Payment Reference Number (FPR) before completing any payment to this office.

Fees are payable in FULL at the time of submission for the following:

• New Research Projects for HREC Review
• Research Projects for Site Specific Assessment (SSA) Review
• Amendments to Approved Research Projects

Credit Card payments are the preferred method of payment

The Research Office no longer accepts payment by cheque

Please Note: Invoice requests for payment by EFT can take up to three weeks to process and the Research Office cannot guarantee review until payment is received in full.

Our submission/review fees are in accordance with NSW Health Fee Policy Guidelines.

Pay online by credit card >

STUDY DEFINITIONS:

St Vincent’s Hospital Sydney has adopted the definitions from VMIA Managed Insurance ‘Guidelines for Clinical Trials’ (2009):

Investigator Initiated Research:

An investigator initiated research project has the following characteristics:

• A pharmaceutical/device company is not acting as the Sponsor for the purposes of the CTN Scheme application
• A pharmaceutical/device company is not directly funding the conduct of the study, that is making payment to the relevant hospital or investigator
• The clinical trial addresses relevant clinical questions and not industry needs
• The Principal Investigator or the Hospital/Institution is the primary author and custodian of the clinical trial protocol

Note – Investigator initiated trials can receive some industry funding or industry contribution, (e.g. educational grants, or supply of medication). However, the support must be declared in the protocol submission, to ensure that the clinical trial retain its “investigator initiated” status.

Commercially Sponsored Research:

A commercially sponsored research project has the following characteristics:

• It is initiated by a pharmaceutical/device company or other commercial entity and not by an investigator at a NSW public health service site
• The research is conducted to investigate a medication/device for commercial exploitation by its manufacturer/sponsor
• The protocol has been developed and is the responsibility of a pharmaceutical/device company or other commercial entity

Co-operative/Collaborative Research:

Co-operative/Collaborative Research has the following characteristics:

• The research must address relevant clinical questions and not pharmaceutical/device industry or commercial needs.
• The co-operative group must declare the nature of any sponsorship from a pharmaceutical entity or any other entity that may directly benefit commercially from the research outcomes.
• The co-operative group must be the primary author and custodian of the clinical trial protocol.

Infrastructure Fee:

St. Vincent's Hospital charges an infrastructure fee on all research projects. Infrastructure charges relate to those that cannot be identified readily (or specifically) with a particular sponsored project. These include maintaining and operating the Hospital's facilities and services including, but not limited to:

• Clinical, laboratory and office space to conduct research and clinical trials activities;
• Utilities including water, electricity, heating, gas and air conditioning;
• Corporate support services including accounting, purchasing, payroll, human resources and legal counsel.